Some studies show promising results in CAR-T-cell therapy, including Li et.al patient with refractory thrombocytopenia of SLE when treated with CAR-T cells, show complete elimination of circulating CD19 B cells within a month [14]. This evidence concerns the gene CD19 and systemic lupus erythematosus.